Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.

Japanese researchers discover a form of brown algae ‘appears to protect against neurodegeneration’ thanks to its antioxidant ...

Parkinson’s disease is the world’s fastest-growing neurological disease. In Part II of her series on the degenerative brain ...

Parkinson's comes on slowly, and diagnosing the often-devastating movement disorder, particularly in its early stages, ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

The Sanofi equity investment means the Big Pharma will receive exclusive rights of first negotiation surrounding VTX3232, an ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.